IPSC vs IR · rev $6.6M vs P/E 49, rev $7.24B
Century Therapeutics Inc (IPSC) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
IPSC currently screens at market cap $47.8M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the IPSC and IR stock pages for the full models.
Not investment advice.